Rapport Therapeutics, Inc. ($RAPP)
PAUL STEVEN M โ Director
Shares
35,714
Price
$27.28
Total Value
$974,277.92
P&L
-4.9% ($48,213.90)
Nearby Earnings
Nov 5, 2026
EPS:Est: -1.20
Transaction Details
| Insider | PAUL STEVEN M |
|---|---|
| Title | Director |
| Transaction Date | Oct 22, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | By Paul Capital Strategy III Fund LLC |
| Filing Date | Oct 22, 2026 |
| Shares Purchased | 35,714 |
| Price per Share | $27.28 |
| Total Value | $974,277.92 |
| Shares Owned After | 77,380 |
| Derivative | No |
| Accession Number | 0001193125-26-429073 |
| Document | View SEC Filing |